ELVERA

Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified chemical compounds for medical purposes, namely, for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified protein arrays for medical use in the therapeutic areas of hematology, inflammation, genetics and metabolism; none of the aforementioned goods being cosmetic skin care preparations and cosmetics

Research and development of pharmaceuticals, protein pharmaceuticals, biological pharmaceuticals, proteins, protein structures, chemical modification of substances, compounds for efficient effect of drugs, compounds for controlled release of pharmaceutical substances within the pharmaceutical field; none of the aforementioned being cosmetic research